Martine A. Rothblatt

Martine A. Rothblatt

DirectoratUnited Therapeutics· In proxies 2021–2025

Pay in FY2025-22% from the year before · United Therapeutics stock +38.1% the same year

Martine A. Rothblatt was paid $18.0M in FY2025 (Dec), down 22%. United Therapeutics stock rose 38.1% that year.

Pay$100 in the stock at the end of FY20 → $321
Pay is from the Summary Compensation Table of each United Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. BETA TechnologiesPublic company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  2. United TherapeuticsPublic company · 5 yr
    • Chairperson and Chief Executive Officer2021 – Present · 5 yrStock in role +291%
  3. BETA Technologies, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?